BRCA1-IRIS overexpression promotes cisplatin resistance in ovarian cancer cells.
Chock
Kerri L
KL
Department of Pathology, John A Burns School of Medicine, University of Hawaii and Cancer Research Center of Hawaii, Honolulu, Hawaii 96813, USA.
Allison
Jamie M S
JM
Shimizu
Yoshiko
Y
ElShamy
Wael M
WM